BIO’s Clinical Trial Disclosure Policy Allows Researchers Access To Data On Approved Medicines
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotechnology Industry Organization’s principles on clinical trial data sharing mirror those released by PhRMA last year; BIO suggests FDA conduct a pilot program on data sharing.